At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Closed 04-07 16:00:00 EDT
1,899.82
-20.32
-1.06%
High1,909.89Low1,884.56Vol26.46M
Open1,904.56D1 Closing1,920.15Amplitude1.32%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O1.11BT/O Rate--Tradable Shares0.00
P/B4.644344ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inovio announces annual shareholder meeting in virtual-only format
Reuters  ·  04:13
Inovio announces annual shareholder meeting in virtual-only format
Tonix publishes investor deck highlighting TONMYA fibromyalgia launch, reports USD 208 million cash
Reuters  ·  02:48
Tonix publishes investor deck highlighting TONMYA fibromyalgia launch, reports USD 208 million cash
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
TIPRANKS  ·  01:30
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
Sector Update: Health Care
MT Newswires Live  ·  01:03
Sector Update: Health Care
Gilead to acquire Tubulis for $3.15B upfront, up to $1.85B in milestone payments
TIPRANKS  ·  04-07 22:31
Gilead to acquire Tubulis for $3.15B upfront, up to $1.85B in milestone payments
Gilead Buying Another Cancer-Drug Partner -- Market Talk
Dow Jones  ·  04-07 22:23
Gilead Buying Another Cancer-Drug Partner -- Market Talk
Gilead Sciences Invests $5 Billion in ADC Sector with Acquisition of Germany's Tubulis
Stock News  ·  04-07 21:17
Gilead Sciences Invests $5 Billion in ADC Sector with Acquisition of Germany's Tubulis
What's Going On With Inovio Pharmaceuticals Stock On Tuesday?
Benzinga_recent_news  ·  04-07 21:15
What's Going On With Inovio Pharmaceuticals Stock On Tuesday?
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
THOMSON REUTERS  ·  04-07 20:30
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
BRIEF-Gilead Sciences To Acquire Tubulis GmbH
Reuters  ·  04-07 20:15
BRIEF-Gilead Sciences To Acquire Tubulis GmbH
Gilead Sciences: to Acquire Tubulis Gmbh
THOMSON REUTERS  ·  04-07 20:15
Gilead Sciences: to Acquire Tubulis Gmbh
Gilead Sciences: Deal Includes up to $1.85 Bln in Contingent Milestone Payments
THOMSON REUTERS  ·  04-07 20:15
Gilead Sciences: Deal Includes up to $1.85 Bln in Contingent Milestone Payments
Gilead Sciences: Will Acquire All of Outstanding Equity of Tubulis for $3.15 Bln in Upfront Cash Consideration on Cash-Free, Debt-Free Basis
THOMSON REUTERS  ·  04-07 20:15
Gilead Sciences: Will Acquire All of Outstanding Equity of Tubulis for $3.15 Bln in Upfront Cash Consideration on Cash-Free, Debt-Free Basis
Gilead Sciences: Plans to Finance Deal With Combination of Cash on Hand & Senior Unsecured Notes
THOMSON REUTERS  ·  04-07 20:15
Gilead Sciences: Plans to Finance Deal With Combination of Cash on Hand & Senior Unsecured Notes
Gilead Agrees to Buy Cancer Biotech Tubulis in $5 Billion Deal - Bloomberg News
THOMSON REUTERS  ·  04-07 20:15
Gilead Agrees to Buy Cancer Biotech Tubulis in $5 Billion Deal - Bloomberg News
Market Chatter: Gilead Sciences to Buy Tubulis for Up to $5 Billion
MT Newswires Live  ·  04-07 20:11
Market Chatter: Gilead Sciences to Buy Tubulis for Up to $5 Billion
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
GlobeNewswire  ·  04-07 20:05
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
Gilead Sciences to Buy Tubulis for Up to $5 Billion, Bloomberg Reports
MT Newswires Live  ·  04-07 20:04
Gilead Sciences to Buy Tubulis for Up to $5 Billion, Bloomberg Reports
Quest Diagnostics announces annual shareholder meeting
Reuters  ·  04-07 04:34
Quest Diagnostics announces annual shareholder meeting
Inovio Pharmaceuticals Announces New Public Equity Offering
TIPRANKS  ·  04-06 21:20
Inovio Pharmaceuticals Announces New Public Equity Offering

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--